Oak Harvest Investment Services Increases Holdings in CME Group Inc. (NASDAQ:CME)

Oak Harvest Investment Services boosted its position in CME Group Inc. (NASDAQ:CME) by 5.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 53,775 shares of the financial services provider’s stock after purchasing an additional 2,639 shares during the period. CME Group comprises 1.7% of Oak Harvest Investment Services’ portfolio, making the stock its 14th biggest holding. Oak Harvest Investment Services’ holdings in CME Group were worth $11,865,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the company. Capital International Investors grew its holdings in CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the period. PineStone Asset Management Inc. boosted its holdings in CME Group by 137.6% in the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after buying an additional 1,309,097 shares during the period. M&G Plc bought a new stake in CME Group during the first quarter valued at about $156,631,000. Assenagon Asset Management S.A. lifted its position in shares of CME Group by 577.9% in the second quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock valued at $126,872,000 after acquiring an additional 550,133 shares in the last quarter. Finally, Ameriprise Financial Inc. boosted its stake in shares of CME Group by 11.3% in the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after acquiring an additional 537,758 shares during the period. 87.75% of the stock is currently owned by institutional investors.

CME Group Trading Up 0.1 %

Shares of NASDAQ CME opened at $227.26 on Thursday. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.36. The business has a fifty day moving average price of $220.05 and a 200 day moving average price of $209.23. The stock has a market capitalization of $81.83 billion, a P/E ratio of 25.85, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the prior year, the company posted $2.25 earnings per share. CME Group’s revenue for the quarter was up 18.4% compared to the same quarter last year. Equities research analysts expect that CME Group Inc. will post 10.04 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Insider Buying and Selling at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sunil Cutinho sold 4,500 shares of the stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total value of $1,019,880.00. Following the sale, the insider now directly owns 27,053 shares in the company, valued at $6,131,291.92. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,221 shares of company stock worth $3,351,895. 0.30% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CME. Morgan Stanley lifted their target price on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Oppenheimer upped their price target on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Piper Sandler lifted their price objective on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday. Royal Bank of Canada restated a “sector perform” rating and set a $235.00 target price on shares of CME Group in a research report on Thursday, October 24th. Finally, The Goldman Sachs Group lifted their price target on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, CME Group presently has an average rating of “Hold” and a consensus target price of $222.73.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.